10.1039/c9nj02154j
The research aims to develop new therapeutic agents with anticancer activities by designing and synthesizing two series of 2,4-diaminopyrimidine derivatives with triazolopiperazine or 1,4,8-triazaspiro[4.5]decan-3-one scaffolds. The study investigates their antitumor activities against various cancer cell lines and explores their structure-activity relationships (SARs). Key chemicals used include 2,4-dichloropyrimidine, various aromatic aldehydes, and different aliphatic amines for side chain modifications. The most promising compounds, 9k and 13f, showed potent antitumor activities with IC50 values in the micromolar range against A549, HCT-116, PC-3, and MCF-7 cell lines. Mechanistic studies revealed that these compounds inhibited cancer cell proliferation, induced apoptosis, suppressed tumor cell migration, and altered cell cycle distribution. The research concludes that these 2,4-diaminopyrimidine derivatives are promising candidates for further development as anticancer agents, with JAK2 identified as a potential target through molecular docking and enzymatic studies.